-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Dactinomycin Offers New Standard for Gestational Trophoblastic Neoplasia From: GIN11153@aol.com Wed Mar 12 13:49:05 2008 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Garry E. Siegel, M.D.: "Gyn: Office hysteroscopy and urodynamics" Previous message: GIN11153@aol.com: "CME/CE credit article" another CEU/CE article _http://www.medpagetoday.com/MeetingCoverage/SGO/dh/8684_ (http://www.medpagetoday.com/MeetingCoverage/SGO/dh/8684) TAMPA, Fla., March 11 -- For patients with low-risk gestational trophoblastic neoplasia, biweekly dactinomycin (Cosmegen) has supplanted weekly methotrexate as the standard of care, suggest results of a multicenter clinical trial. Significantly more patients had complete responses with dactinomycin, and the two agents had similar tolerability profiles, Ray Osborne, M.D., of the University of Toronto, reported at the Society of Gynecologic Oncologists meeting here. Gail Next message: Garry E. Siegel, M.D.: "Gyn: Office hysteroscopy and urodynamics" Previous message: GIN11153@aol.com: "CME/CE credit article"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Jul 2 04:49:04 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.